latest news releases from the newsroom
Bassett Furniture Industries, Inc.
Bassett and Costa Brava End Potential Proxy Contest
BASSETT, Va. and BOSTON, Mass., April 10, 2008 (PRIME NEWSWIRE) -- Bassett Furniture Industries Inc. (Nasdaq:BSET) and Costa Brava Partnership III L.P. today announced that they have resolved their potential proxy contest.
Globalstar Announces Pricing of $135 Million of 5.75 Percent Convertible Senior Notes and Entry Into a Share Lending Agreement
MILPITAS, Calif., April 10, 2008 (PRIME NEWSWIRE) -- Globalstar, Inc. (Nasdaq:GSAT), a leading provider of mobile satellite voice and data services to businesses, governments, and individuals, today announced that it has priced its previously announced offering of $135 million of 5.75% Convertible Senior Notes due 2028 (the "Notes"). Globalstar also announced it has granted the underwriters of the Notes offering a 30-day option to purchase an additional $15 million aggregate principal amount of the Notes, solely to cover overallotments. Merrill Lynch, Pierce, Fenner & Smith Incorporated ("Merrill Lynch") and Deutsche Bank Securities Inc. are joint Book-Running Managers for the offering.
EDAP TMS SA
EDAP Adds World Renowned Cancer Center for Phase II/III Ablatherm-HIFU Clinical Trial
LYON, France, April 10, 2008 (PRIME NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it has received Institutional Review Board (IRB) approval for Memorial Sloan-Kettering Cancer Center in New York City to participate in EDAP's ongoing Phase II/III clinical trial of Ablatherm(r)-High Intensity Focused Ultrasound (HIFU). The trial compares the outcomes of Ablatherm and Cryotherapy for the treatment of low-risk prostate cancer. This IRB approval brings the total number of active sites in the trial to 10 HIFU sites and 6 Cryotherapy sites.